LumiCleanse
Commercial- Indications
- Acne vulgaris
Company intelligence / Profile preview
Klox Technologies has developed and commercialized fluorescent light energy systems for regenerative medicine. Its FLE technology has been launched under the LumiHeal® and Kleresca® brands for wound care, dermatology, oral health, and veterinary applications. The company holds at least 35 patents related to biophotonic compositions for medical treatments such as inhibiting biofilms or treating acneiform eruptions. Clinical results have led to international commercialization of their dental whitening procedures and tissue repair solutions; however specific clinical trial data are not detailed in public sources.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Klox Technologies.